It is a pharma private limited company based in Kottayam, Kerala, India, established in 1996.
1996 | Kottayam, Kerala, India | ActiveKannikkatt Pharmaceuticals Private Limited, a active private limited company, was established on 20 March 1996 in Kottayam, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231KL1996PTC010177. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Kannikkat Mathew Jose (Managing Director), Alka Jose (Director), Daisy Jose (Director). Past directors included Kannikkatt Mathew George, Kannikkatt Mathew Francis, Vini Paul. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Building No. Kmc Xiv/360C Kannikkatt Buildings, Kodimatha. P.O., Kottayam, Kerala, 686039.
U24231KL1996PTC010177
010177
20 March 1996
₹1.00 M
₹1.00 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Kannikkatt Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kannikkat Mathew Jose | Managing Director | 20 Mar 1996 | Current |
| Alka Jose | Director | 29 Jul 2009 | Current |
| Daisy Jose | Director | 29 Jul 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2009 | Past |
| Pramod Abcsdd | Director | 01 Apr 2009 | Past |
| Pramod Abcsdd | Director | 01 Apr 2011 | Past |
| Pramod Abcsdd | Director | 01 Apr 2011 | Past |
| Pramod Abcsdd | Additional Director | 31 Oct 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kannikkatt Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.16% increase. The company also saw a substantial fall in profitability, with a 254.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kannikkatt Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kannikkatt Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kannikkatt Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kannikkatt Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kannikkatt Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Kannikkatt Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on Alka Jose was appointed as a Director was appointed as a Director on 29 Jul 2009 & has been associated with this company since 16 years 4 months . was documented.
The activity Daisy Jose was appointed as a Director was appointed as a Director on 29 Jul 2009 & has been associated with this company since 16 years 4 months . was completed.
The activity Kannikkat Mathew Jose was appointed as a Managing Director was appointed as a Managing Director on 20 Mar 1996 & has been associated with this company since 29 years 8 months . was completed.
Progress on Kannikkatt Pharmaceuticals Private Limited was registered on 20 Mar 1996 with Roc Ernakulam & aged 29 years 8 months as per MCA records. was documented.
The CIN of Kannikkatt Pharmaceuticals Private Limited is U24231KL1996PTC010177.
Kannikkatt Pharmaceuticals Private Limited is headquartered at Building No. Kmc Xiv/360C Kannikkatt Buildings, Kodimatha. P.O., Kottayam, Kerala, 686039.
Kannikkatt Pharmaceuticals Private Limited was incorporated on 20 March 1996.
The current directors of Kannikkatt Pharmaceuticals Private Limited are
The primary industry of Kannikkatt Pharmaceuticals Private Limited is Manufacturing.
Kannikkatt Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kannikkatt Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Kannikkatt Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX